
Currently out of the existing stock ratings of Nick Abbott, 8 are a HOLD (72.73%), 3 are a BUY (27.27%).
Analyst Nick Abbott, has had 75% of price targets met with an average potential upside of 48.84%, reached in 318 days on average. Previously, Nick Abbott worked at WELLS FARGO.
Nick Abbott has documented 20 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 30-May-2023.
Analyst best performing recommendations are on IOVA (IOVANCE BIOTHERAPEUTICS).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) on 10/6/2020. The price target of $50 was fulfilled within 69 days with a profit of $21.9 (77.94%), with a performance score of 11.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Feb-2026
$200
$-15.27 (-7.09%)
$95
4 days ago
(16-Nov-2026)
0/5 (0%)
$-15.27 (-7.09%)
0
Sell Since 03-Nov-2024
$102
$-113.27 (-52.62%)
$77
4 days ago
(16-Nov-2026)
15/17 (88.24%)
$-113.27 (-52.62%)
68
5.51
Buy Since 01-Jan-2019
$305
$89.73 (41.68%)
$230
12 days ago
(08-Nov-2026)
67/81 (82.72%)
$50.81 (19.99%)
265
7.86
Hold Since 12-Feb-2025
$195
$-20.27 (-9.42%)
$137
12 days ago
(08-Nov-2026)
22/36 (61.11%)
$-59.19 (-23.29%)
223
5.28
Hold Since 02-Nov-2023
$90
$-125.27 (-58.19%)
$25
1 months ago
(20-Oct-2026)
19/20 (95%)
$-155.81 (-63.39%)
198
5.81